When was Biose founded?

Biose was founded in 2013 and raised its 1st funding round 6 years after it was founded.

Where is Biose located?

Biose is headquartered in Clermont Ferrand, France.

How many employees does Biose have?

As of Aug 31, 2026, the latest employee count at Biose is 224.

Is Biose a funded company?

Biose is a funded company, having raised a total of $34.2M across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jan 01, 2019.

When was the latest funding round of Biose?

Biose's latest funding was a $***** Series C round on Jul 16, 2020, with participation from 1 investor.

Where does Biose rank among its competitors?

Biose ranks 41st amongst 350 active competitors, of which 22 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Abingdon Health, which secured $4.4M in Oct, 2025.

Who are the top competitors of Biose?

Biose's top competitors include Anthem Biosciences, Patheon and Aragen. Among them, Abingdon Health secured the most recent funding round in October, 2025.

Biose - 2026 Company Profile, Funding & Competitors

Biose is an acquired company based in Clermont Ferrand (France), founded in 2013. It operates as a Provider of therapeutic macrobiotic ranges for human health. Biose has raised $34.2M in funding from Cathay Capital. The company has 350 active competitors, including 22 funded and 99 that have exited. Its top competitors include companies like Anthem Biosciences, Patheon and Aragen.

Company Details

Biose is a provider of therapeutic macrobiotic ranges for human health. The company offers pharmaceutical laboratories and biotechs around the world a complete and integrated offer to carry out the entire production process of these drugs, from process development to production of finished products.

Website: www.biose.com/
Social

Key Metrics

Founded Year

2013

Location

Clermont Ferrand, France

Stage

Acquired

Total Funding

$34.2M in 2 rounds

Latest Funding Round

Series C, Jul 16, 2020, $*****

Investors

Cathay Capital & 2 more

Ranked

41^st among 350 active competitors

Employee Count

224 as on Aug 31, 2026

Similar Companies

KBI Biopharma & 161 more

Exit Details

Acquired by L-GAM (Feb 22, 2023)

View Biose's full profile

Biose is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
BIOSE INDUSTRIE INC CIN: 611978320 , United States, Active	Dec 31, 1999	-	3 (As on Dec 31, 2024)	-

Biose got acquired by L-GAM and Bpifrance on Feb 22, 2023.

Click here to take a look at Biose's acquisition in detail

Biose has raised a total funding of $34.2M over 2 rounds. Its first funding round was on Jan 01, 2019. Its latest funding round was a Series C round on Jul 16, 2020 for $*****. 1 investor participated in its latest round. Biose has 3 institutional investors.

Here is the list of recent funding rounds of Biose:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 16, 2020	6767264	Series C	2949266	4322273	5189899	7492533
Jan 01, 2019	5977776	Grant (prize money)	6864082	8824876	3916271	8951173

Access funding benchmarks and valuations. Sign up today!

View details of Biose's funding rounds and investors

Biose's employee count trend

Biose has 224 employees as of Aug 26. Here is Biose's employee count trend over the years:

Uncover Biose's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Biose include Anthem Biosciences, Patheon and Aragen. Here is the list of Top 10 competitors of Biose, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Anthem Biosciences 2006, Bengaluru (India), Public	Developer of integrated contract research development and manufacturing services	$35.7M	Portsmouthtechnologiestrialsunit, True North ... & 8 others	76/100
2nd	Patheon 1974, Durham (United States), Acquired	Global CDMO providing integrated drug development, clinical trials, and manufacturing services	$141M	Frazier Healthcare Partners, Audax Group & 3 others	74/100
3rd	Aragen 2001, Hyderabad (India), Series B	Provider of drug discovery, clinical development, manufacturing, and other services for small molecules	$161M	Goldman Sachs, Quadria Capital & 18 others	69/100
4th	KBI Biopharma 1996, Durham (United States), Acquired	Provider of protein formulation, process & cell line development, and cGMP services	$21M	Ballast Point Ventures, NCBiotech & 1 others	69/100
5th	Syngene 1993, Bengaluru (India), Public	Provider of contract research and manufacturing services for both small molecules and biologics	$85.9M	True North, Education Growth Partners & 9 others	66/100
6th	Abzena 2001, Cambridge (United Kingdom), Acquired	Provider of antibody discovery, cell line development, and bio analytics services	$67.1M	Imperial Innovations, Invesco Perpetual & 11 others	66/100
7th	Abingdon Health 2008, York (United Kingdom), Public	Developer of immunoassays for diagnostic purposes	$24.1M	Imperial Innovations, Mercia & 2 others	64/100
8th	Grand River Aseptic Manufacturing 2010, Grand Rapids (United States), Acquired	Aseptic manufacturing CDMO providing fill-finish services for sterile injectables	$16.9M	Municipal Employees' Retirement System, Trout Creek Ventures ... & 5 others	59/100
9th	EirGenix 2012, Taipei (Taiwan), Public	Contract development and manufacturing organization for biologics	-	CDIB Capital Group, Taiwania Capital & 3 others	58/100
10th	Piramal Pharma Solutions 1988, Mumbai (India), Unfunded	Contract manufacturer of pharmaceutical products	-	Thecarlylegroup.fr	58/100
41st	Biose 2013, Clermont Ferrand (France), Acquired	Provider of therapeutic macrobiotic ranges for human health	$34.2M	Cathay Capital, Siparex & 1 others	45/100